{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T04:29:44Z","timestamp":1780806584745,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Government of India Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/RLF\/Re-entry\/25\/2012"],"award-info":[{"award-number":["BT\/RLF\/Re-entry\/25\/2012"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.dld.2024.08.050","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T23:40:32Z","timestamp":1726616432000},"page":"427-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["NOSTRIN is an emerging positive regulator of decompensated cirrhotic patients with portal hypertension"],"prefix":"10.1016","volume":"57","author":[{"given":"Balasubramaniyan","family":"Vairappan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravikumar","family":"TS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit Kumar","family":"Ram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pazhanivel","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biju","family":"Pottakkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2024.08.050_bib0001","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gines","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2024.08.050_bib0002","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1056\/NEJMra1914900","article-title":"Acute-on-chronic liver failure","volume":"382","author":"Arroyo","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2024.08.050_bib0003","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2024.08.050_bib0004","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2024.08.050_bib0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4254\/wjh.v7.i3.443","article-title":"Endothelial dysfunction in cirrhosis: role of inflammation and oxidative stress","volume":"7","author":"Vairappan","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.dld.2024.08.050_bib0006","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1172\/JCI1699","article-title":"Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling","volume":"101","author":"Rudic","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dld.2024.08.050_bib0007","doi-asserted-by":"crossref","first-page":"17900","DOI":"10.1038\/s41598-017-18094-3","article-title":"Post-transcriptional regulation of hepatic DDAH1 with TNF blockade leads to improved eNOS function and reduced portal pressure in cirrhotic rats","volume":"7","author":"Balasubramanian","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2024.08.050_bib0008","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.21491","article-title":"Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis","volume":"45","author":"Mookerjee","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.08.050_bib0009","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.21905","article-title":"The puzzle of endothelial nitric oxide synthase dysfunction in portal hypertension: the missing piece?","volume":"46","author":"Mookerjee","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.08.050_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176010","article-title":"Candesartan cilexetil ameliorates NOSTRIN-NO dependent portal hypertension in cirrhosis and ACLF","volume":"958","author":"Vairappan","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.dld.2024.08.050_bib0011","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1478-3231.2011.02579.x","article-title":"Endothelial dysfunction in the regulation of cirrhosis and portal hypertension","volume":"32","author":"Iwakiri","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2024.08.050_bib0012","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1053\/j.gastro.2006.12.035","article-title":"Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis","volume":"132","author":"Mookerjee","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.08.050_bib0013","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/liv.12613","article-title":"Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertension","volume":"35","author":"Trebicka","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2024.08.050_bib0014","doi-asserted-by":"crossref","first-page":"9497","DOI":"10.1073\/pnas.1918761117","article-title":"Unbiased proteomics identifies plasminogen activator inhibitor-1 as a negative regulator of endothelial nitric oxide synthase","volume":"117","author":"Garcia","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.dld.2024.08.050_bib0015","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1242\/jcs.02620","article-title":"NOSTRIN functions as a homotrimeric adaptor protein facilitating internalization of eNOS","volume":"118","author":"Icking","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.dld.2024.08.050_bib0016","doi-asserted-by":"crossref","first-page":"17167","DOI":"10.1073\/pnas.252345399","article-title":"NOSTRIN: a protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase","volume":"99","author":"Zimmermann","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.dld.2024.08.050_bib0017","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0016-5085(99)70408-7","article-title":"Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat","volume":"117","author":"Shah","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.08.050_bib0018","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/14767058.2014.900036","article-title":"The relation of maternal serum eNOS, NOSTRIN and ADMA levels with aetiopathogenesis of preeclampsia and\/or intrauterine fetal growth restriction","volume":"28","author":"Laskowska","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.dld.2024.08.050_bib0019","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/ATVBAHA.110.216200","article-title":"Platelet-endothelial cell adhesion molecule-1 regulates endothelial NO synthase activity and localization through signal transducers and activators of transcription 3-dependent NOSTRIN expression","volume":"31","author":"McCormick","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.dld.2024.08.050_bib0020","doi-asserted-by":"crossref","first-page":"9416","DOI":"10.1021\/bi800682k","article-title":"Dynamical characterization of the heme NO oxygen binding (HNOX) domain. Insight into soluble guanylate cyclase allosteric transition","volume":"47","author":"Capece","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.dld.2024.08.050_bib0021","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2014.03.014","article-title":"Inflammation and portal hypertension - the undiscovered country","volume":"61","author":"Mehta","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2024.08.050_bib0022","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2004.12.041","article-title":"Expression of endothelial nitric oxide synthase traffic inducer in the placentas of women with pre-eclampsia","volume":"89","author":"Xiang","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.dld.2024.08.050_bib0023","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2249.2009.03916.x","article-title":"An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease","volume":"156","author":"Lemmers","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.dld.2024.08.050_bib0024","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MEG.0b013e328351db6e","article-title":"High-sensitivity C-reactive protein levels predict survival and are related to haemodynamics in alcoholic cirrhosis","volume":"24","author":"Mortensen","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.08.050_bib0025","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.21875","article-title":"High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats","volume":"46","author":"Thabut","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.08.050_bib0026","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/gut.52.8.1182","article-title":"Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis","volume":"52","author":"Mookerjee","year":"2003","journal-title":"Gut"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824009691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824009691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T12:49:00Z","timestamp":1741178940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865824009691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1590865824009691"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2024.08.050","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NOSTRIN is an emerging positive regulator of decompensated cirrhotic patients with portal hypertension","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2024.08.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}